ARTICLE | Company News
Corixa, Ganymed deal
June 14, 2004 7:00 AM UTC
Ganymed granted CRXA and partner Kirin Brewery Co. Ltd., (Tokyo, Japan) a license to Wilm's tumor antigen ( WT1) immunotherapy patents. CRXA and Kirin are developing WT1 cancer vaccines to treat leuk...